Multi-cancer blood tests like Galleri are gaining attention for their ability to detect cancers without routine screening.

Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...

Exact Sciences’ Tomasz Beer, MD, explains how multi-cancer early detection is moving out of research and into practice—bringing new clinical and operational considerations with it ...

Cancerguard by Exact Sciences is the first of its kind early detection blood test for multiple kinds of cancer. Exact Sciences is a diagnostic company focusing on early cancer detection. Cancerguard ...

Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...

Grey’s Anatomy star Kate Walsh called this decision a “no brainer” in both a serious and punny way. It’s her decision to team up with the company GRAIL to advocate for more multi-cancer early ...

MCED is able to detect multiple cancer types by analyzing cfDNAs, cfRNAs, circulating proteins and metabolites using liquid-based biopsy techniques and AI algorithms. The TOO results of an MCED test ...

(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...